tradingkey.logo

Sharps Technology Inc

STSS
查看詳細走勢圖
1.650USD
+0.225+15.79%
收盤 02/06, 16:00美東報價延遲15分鐘
45.58M總市值
虧損本益比TTM

Sharps Technology Inc

1.650
+0.225+15.79%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+15.79%

5天

-20.29%

1月

-34.00%

6月

-65.70%

今年開始到現在

-18.72%

1年

-98.53%

查看詳細走勢圖

TradingKey Sharps Technology Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Sharps Technology Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值合理,在醫療設備與耗材行業排名151/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為22.00。中期看,股價處於下降通道。近一個月,市場表現較差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Sharps Technology Inc評分

相關信息

行業排名
151 / 205
全市場排名
517 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Sharps Technology Inc亮點

亮點風險
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入0.00美元
估值高估
公司最新PE估值-0.00,處於3年歷史高位
機構加倉
最新機構持股5.29M股,環比增加40.64%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉521.63K股

分析師目標

基於 0 分析師
--
評級
22.000
目標均價
+877.78%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Sharps Technology Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Sharps Technology Inc簡介

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
公司代碼STSS
公司Sharps Technology Inc
CEOMr. Robert M. Hayes
網址https://sharpstechnology.com/
KeyAI